Skip to main content
. Author manuscript; available in PMC: 2024 May 16.
Published in final edited form as: Vaccine. 2023 Apr 24;41(21):3367–3379. doi: 10.1016/j.vaccine.2023.04.042

Table 2:

Standard membrane feeding assay using monoclonals purified from serum-free hybridoma media using Protein G.

Immuno-blot Sample name IgG conc [µg/ml] % Uninfect Oocyst % Inhibition
Range Ave Estimate 95% CI Lo 95% CI Hi p-valu e
Human serum 0 0 16–90 56.1
Pfs25 4B7 93.8 5 0–19 5.4 90.5 72.1 96.8 0.001
Neg Ctrl F2 03G2 1A12 375.0 5 0–123 43.8
Pfs230 F3 09F4 5E1 375.0 100 0 0.0 100.0 99.7 100.0 0.001
F5 6D11 7E5 375.0 80 0–2 0.3 99.4 97.4 100.0 0.001
F5 05A6 2F5 90.0 25 0–33 8.0 81.7 52.1 93.8 0.003
Pfs48/45 F2 14E5 1G9 375.0 10 0–29 5.6 87.3 63.8 95.7 0.001
Pfs25 F5 04F5 2C7 375.0 55 0–5 1.0 97.7 92.7 99.4 0.00 1
F3 09B9 1H1 375.0 60 0–7 1.6 96.5 89.9 98.9 0.001
Neg F6 30C5 11A6 375.0 60 0–6 0.9 97.9 93.9 99.4 0.001
F3 14A1 2H11 375.0 30 0–46 9.3 78.9 36.7 93.1 0.006
Human serum 0 0 18–98 58.4
Pfs25 4B7 93.8 25 0 – 9 2.9 95.0 89.0 97.9 0.001
Neg Ctrl F2 03G2 1A12 375.0 0 9 – 70 36.4
Pfs230 F3 09F4 5E1 375.0 80 0 – 1 0.2 99.5 98.8 99.8 0.001
93.8 80 0 – 1 0.2 99.5 98.5 99.9 0.001
F5 6D11 7E5 375.0 90 0–2 0.2 99.5 98.0 100.0 0.001
93.8 70 0–4 0.6 98.4 95.2 100.0 0.001
F5 05A6 2F5 75.0 0 6–72 31.1 14.6 −138.5 71.4 0.746
Pfs48/45 F2 14E5 1G9 375.0 5 0 – 46 16.4 54.9 0.1 79.5 0.050
93.8 5 0 – 35 11.3 69.0 30.6 86.2 0.011
Pfs25 F5 04F5 2C7 375.0 70 0 – 3 0.6 98.5 96.4 99.4 0.001
93.8 30 0 – 16 3.9 89.4 75.3 95.3 0.001
F3 09B9 1H1 375.0 35 0 – 7 1.3 96.4 92.1 98.5 0.001
93.8 5 0 – 28 9.4 74.2 34.7 90.7 0.003
Neg F6 30C5 11A6 375.0 30 0 – 5 1.9 94.9 88.4 98.0 0.001
93.8 5 0–34 13.3 63.6 16.4 84.0 0.017
F3 14A1 2H11 375.0 0 2–47 22.3 38.6 −36.2 73.4 0.235
93.8 5 0–39 18.1 50.3 −10.1 79.2 0.090